Besides opnMe, Koester established scientific crowdsourcing as a new open innovation tool to attract externally generated new therapeutic concepts for Boehringer Ingelheim’s pre-clinical pipeline.
5mon
GlobalData on MSNBoehringer Ingelheim reports positive results from trial of HER2 lung cancer drugBoehringer Ingelheim Innovation Unit head Paola Casarosa said: “Zongertinib’s efficacy and tolerability profile has the ...
Hosted on MSN7mon
Boehringer Ingelheim India enters into second collaboration with SIIC IIT Kanpur to support healthcare innovationBoehringer Ingelheim's support aligns perfectly with our vision to create a healthy India for all. It enables us to empower the startup community, fostering an ecosystem of innovation and ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results